Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United Therapeutics (UTHR) Goodwill & Intangibles (2016 - 2025)

United Therapeutics' Goodwill & Intangibles history spans 16 years, with the latest figure at $32.3 million for Q4 2025.

  • For Q4 2025, Goodwill & Intangibles fell 71.13% year-over-year to $32.3 million; the TTM value through Dec 2025 reached $32.3 million, down 71.13%, while the annual FY2025 figure was $32.3 million, 71.13% down from the prior year.
  • Goodwill & Intangibles for Q4 2025 was $32.3 million at United Therapeutics, down from $116.7 million in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $116.7 million in Q3 2025 and bottomed at $32.3 million in Q4 2025.
  • The 5-year median for Goodwill & Intangibles is $44.7 million (2021), against an average of $76.3 million.
  • The largest annual shift saw Goodwill & Intangibles plummeted 71.79% in 2021 before it soared 159.33% in 2024.
  • A 5-year view of Goodwill & Intangibles shows it stood at $44.6 million in 2021, then decreased by 0.22% to $44.5 million in 2022, then surged by 156.63% to $114.2 million in 2023, then fell by 2.01% to $111.9 million in 2024, then tumbled by 71.13% to $32.3 million in 2025.
  • Per Business Quant, the three most recent readings for UTHR's Goodwill & Intangibles are $32.3 million (Q4 2025), $116.7 million (Q3 2025), and $111.5 million (Q2 2025).